Enzymes in Breast Cyst Fluid and Their Link to Cancer Risk
Author Information
Author(s): KL Frame, K Patton, MJ Reed, MW Ghilchik, DC Parish
Primary Institution: St Mary's Hospital Medical School, Imperial College of Science, Technology & Medicine
Hypothesis
Higher levels of peptidases in breast cyst fluid may reflect a protective environment against breast cancer.
Conclusion
The study found that angiotensin-converting enzyme levels are significantly higher in type 2 breast cyst fluid compared to type 1, suggesting a potential protective role.
Supporting Evidence
- Type 2 breast cyst fluid had significantly higher ACE levels than type 1.
- ACE activity was inversely correlated with serum ACE levels.
- Peptidases in breast cyst fluid may modulate the growth of carcinomas.
Takeaway
This study looked at fluids from breast cysts to see if certain enzymes could help protect against breast cancer. They found that one enzyme was higher in a type of cyst that is less likely to lead to cancer.
Methodology
Breast cyst fluid was obtained by needle aspiration and analyzed for enzyme activity using various assays.
Limitations
The study did not determine the exact origin of the peptidases in breast cyst fluid.
Participant Demographics
Women attending the breast clinic at St Mary's Hospital, London.
Statistical Information
P-Value
0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website